P3 Health Partners Inc. (PIIIW) income statement

PIIIWNasdaqServices-Health ServicesFiscal year ends December 31Also trades as PIII

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 4/30

$0.01+0.00 (+14.89%)

Close on Oct 30, 2026Market cap $29.26MP/E –Yield –

P3 Health Partners Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q2 2026 2026-06-30	TTM Q1 2026 2026-03-31	TTM FY 2025 2025-12-31	TTM Q3 2025 2025-09-30	TTM Q2 2025 2025-06-30	TTM Q1 2025 2025-03-31	TTM FY 2024 2024-12-31	TTM Q3 2024 2024-09-30	TTM Q2 2024 2024-06-30	TTM Q1 2024 2024-03-31	TTM FY 2023 2023-12-31	TTM Q3 2023 2023-09-30	TTM FY 2022 2022-12-31
Revenue	1,503	1,472	1,459	1,445	1,462	1,485	1,500	1,477	1,403	1,353	1,266	1,178	1,049
Selling, General & Admin	–	108	107	103	108	111	114	107	114	115	126	142	162
Selling & Marketing	–	0.96	0.92	1.04	0.93	1.19	1.33	1.59	2.11	2.55	3.23	4.22	5.10
General & Administrative	116	107	106	102	107	110	113	106	112	112	122	138	157
Operating Expenses	1,651	1,696	1,729	1,700	1,780	1,800	1,821	1,723	1,576	1,516	1,434	1,818	2,610
Operating Income	-149	-224	-270	-255	-318	-315	-321	-246	-173	-163	-168	-640	-1,561
Other Non-Operating Income	-79	-62	-51	-24	2.20	13	15	-2.72	-6.31	-16	-16	-6.64	1.22
Asset Impairment Charges	–	–	–	–	–	–	–	–	–	–	0	–	1,315
Gain (Loss) on Sale of Assets	–	–	-0.16	–	–	–	13	–	–	–	–	–	–
Pretax Income	-227	-286	-321	-279	-316	-302	-306	-249	-180	-179	-184	-647	-1,560
Income Tax Expense	-11	-10	2.03	8.02	4.40	3.39	4.39	1.20	5.22	4.48	2.70	2.79	1.86
Net Income incl. Noncontrolling Interests	-218	-277	-323	-263	-296	-264	-310	-203	-137	-135	-186	-589	-1,562
Minority Interest in Earnings	-118	-150	-175	-155	-174	-167	-175	-148	-115	-116	-129	-523	-1,291
Net Income	-98	-126	-148	-131	-146	-138	-136	-103	-69	-67	-58	-126	-270
Net Income to Common	–	–	–	–	–	–	–	–	–	–	–	–	-270
EPS (Basic)(per share)	-32.95	-38.55	-45.26	-40.17	-44.86	-43.03	-46.78	-37.64	-29.28	-29.38	-30.50	-134.57	-325.00
EPS (Diluted)(per share)	-33.00	-38.60	-45.26	-40.19	-46.22	-47.36	-54.06	-34.99	-25.29	-22.42	-31.50	-134.57	-325.00
Shares Outstanding (Basic, Weighted)(shares)	3.30	3.28	3.27	3.26	3.26	3.12	2.90	2.66	2.43	2.28	1.90	1.52	0.83
Shares Outstanding (Diluted, Weighted)(shares)	4.58	4.56	3.27	3.26	3.27	3.16	2.94	3.69	4.43	4.26	5.89	2.52	0.83
EBITDA	-64	-140	-186	-171	-233	-229	-235	-160	-87	-76	-81	-553	-1,474
Net Interest Income	-61	-63	-55	-46	-31	-27	-22	-19	-18	-16	-16	-15	-11

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -9.9%
Net margin: -6.6%
Return on equity, FY2025: 373.2%

Financial strength

Current ratio: 0.46
Debt to equity: –
Debt to assets: 18.4%
Cash to current liabilities: 5.5%

Valuation

P/E ratio: –
Price to sales: 0.02
Price to book: –
Dividend yield: –